Results 11 to 20 of about 243,507 (261)

Effects of Single Vitamin D Injection (200,000 Units) on Serum Fibroblast Growth Factor 23 and Sclerostin Levels in Subjects with Vitamin D Deficiency [PDF]

Endocrinology and Metabolism, 2017
BackgroundVitamin D deficiency remains common in all age groups and affects skeletal and non-skeletal health. Fibroblast growth factor 23 is a bone-derived hormone that regulates phosphate and 1,25-dihydroxyvitamin D homeostasis as a counter regulatory ...
Dongdong Zhang, Da Hea Seo, Han Seok Choi, Hye-Sun Park, Yoon-Sok Chung, Sung-Kil Lim   +5 more
doaj   +1 more source

Fibroblast Growth Factor 23 and Inflammation in CKD [PDF]

Clinical Journal of the American Society of Nephrology, 2012
Summary Background and objectives Levels of fibroblast growth factor 23 (FGF23) and inflammatory markers are commonly elevated in CKD, and each is associated with adverse clinical outcomes. This study tested the hypothesis that FGF23 is independently associated with inflammation in CKD.
Jair, Munoz Mendoza, Tamara, Isakova, Ana C, Ricardo, Huiliang, Xie, Sankar D, Navaneethan, Amanda H, Anderson, Lydia A, Bazzano, Dawei, Xie, Matthias, Kretzler, Lisa, Nessel, L Lee, Hamm, Lavinia, Negrea, Mary B, Leonard, Dominic, Raj, Myles, Wolf   +14 more
openaire   +2 more sources

How Fibroblast Growth Factor 23 Works [PDF]

Journal of the American Society of Nephrology, 2007
There is a discontinuum of hereditary and acquired disorders of phosphate homeostasis that are caused by either high or low circulating levels of the novel phosphaturic hormone fibroblastic growth factor 23 (FGF23). Disorders that are caused by high circulating levels of FGF23 are characterized by hypophosphatemia, decreased production of 1,25 ...
Shiguang, Liu, L Darryl, Quarles
openaire   +2 more sources

Fibroblast growth factor 23: fueling the fire [PDF]

Kidney International, 2016
In chronic kidney disease, systemic inflammation is common and associated with mortality. The present study demonstrates that fibroblast growth factor 23 (FGF23) contributes to uremic inflammation by increasing hepatic expression and secretion of inflammatory cytokines.
Hanudel, Mark, Jüppner, Harald, Salusky, Isidro B   +2 more
openaire   +4 more sources

Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism

PLoS ONE, 2022
This ad hoc analysis of a previously conducted phase 3 head-to-head comparison study of evocalcet and cinacalcet in secondary hyperparathyroidism patients undergoing maintenance hemodialysis evaluated the efficacy and safety of combined once-daily oral ...
Takashi Shigematsu, Shinji Asada, Yuichi Endo, Takehisa Kawata, Masafumi Fukagawa, Tadao Akizawa   +5 more
doaj   +2 more sources

Il Fibroblast Growth Factor-23 (FGF-23)

Giornale di Clinica Nefrologia e Dialisi, 2018
Negli ultimi due decenni, l'identificazione delle proprietà biologiche del Fibroblast Growth Factor 23 (FGF23) ha notevolmente ampliato le conoscenze sulla regolazione endocrina e paracrina dell'omeostasi dei fosfati e sulle relazioni intercorrenti tra ...
D. Rendina, G. De Filippo, R. Muscariello, F. De Pascale, P. Strazzullo   +4 more
doaj   +1 more source

Neurofibromatosis type 1 associated with hypophosphatemic osteomalacia due to hypersecretion of fibroblast growth factor 23: a case report

Journal of Medical Case Reports, 2020
Background Neurofibromatosis type 1 is characterized by multiple café au lait spots and cutaneous and plexiform neurofibromas, and is one of the most common autosomal dominant hereditary disorders caused by mutations of the neurofibromatosis type 1 tumor
Takahiko Obo, Nobuyuki Koriyama, Akinori Tokito, Kazuma Ogiso, Yoshihiko Nishio   +4 more
doaj   +1 more source

Fibroblast Growth Factor-23 (FGF-23) e Sindrome Cardiorenale

Giornale di Clinica Nefrologia e Dialisi, 2015
non disponibile (Cardionephrology)
Luca Di Lullo, Rodolfo Rivera, Antonio De Pascalis, Fulvio Floccari, Vincenzo Barbera, Claudio Ronco, Alberto Santoboni1   +6 more
doaj   +1 more source

Serum intact fibroblast growth factor 23 in healthy paediatric population

Open Medicine, 2021
It is believed that fibroblast growth factor 23 (FGF23) can become an early biomarker of chronic kidney disease progression. Data on FGF23 age dependency are inconsistent.
Stanczyk Malgorzata, Chrul Slawomir, Wyka Krystyna, Tkaczyk Marcin   +3 more
doaj   +1 more source

Fibroblast Growth Factor-23 and a Vegetarian Diet [PDF]

Journal of Renal Nutrition, 2020
Sparse data exist on population distributions of serum fibroblast growth factor-23 (FGF23) levels from developing, middle-income economies. FGF23 levels may differ substantially across regions based on differences in diet and urbanization. In a population-based study from North India, we tested the hypothesis that urinary phosphate excretion and FGF23 ...
Shuchi Anand, Ram Jagannathan, Ruby Gupta, Sailesh Mohan, Dorairaj Prabhakaran, Myles Wolf   +5 more
openaire   +2 more sources